These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38669059)

  • 1. Design, Synthesis, and Evaluation of Dihydropyrimidine Derivatives as Selective PDE1 Inhibitors for the Treatment of Liver Fibrosis.
    Zhao ZJ; Jiang MY; Huang MX; Yang YY; Feng LL; Zhang C; Huang YY; Luo HB; Wu Y
    J Med Chem; 2024 May; 67(10):8309-8322. PubMed ID: 38669059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of polycyclic pyrazolo[3,4-d]pyrimidines as PDE1 and PDE5 cGMP phosphodiesterase inhibitors.
    Xia Y; Chackalamannil S; Czarniecki M; Tsai H; Vaccaro H; Cleven R; Cook J; Fawzi A; Watkins R; Zhang H
    J Med Chem; 1997 Dec; 40(26):4372-7. PubMed ID: 9435906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Novel Selective and Orally Bioavailable Phosphodiesterase-1 Inhibitors for the Efficient Treatment of Idiopathic Pulmonary Fibrosis.
    Wu Y; Tian YJ; Le ML; Zhang SR; Zhang C; Huang MX; Jiang MY; Zhang B; Luo HB
    J Med Chem; 2020 Jul; 63(14):7867-7879. PubMed ID: 32603117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Modifications of Nimodipine Lead to Novel PDE1 Inhibitors with Anti-pulmonary Fibrosis Effects.
    Huang MX; Tian YJ; Han C; Liu RD; Xie X; Yuan Y; Yang YY; Li Z; Chen J; Luo HB; Wu Y
    J Med Chem; 2022 Jun; 65(12):8444-8455. PubMed ID: 35666471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of novel pyrazolopyrimidone derivatives as potent PDE1 inhibitors.
    Zhang B; Huang Y; Zhang SR; Huang MX; Zhang C; Luo HB
    Bioorg Chem; 2021 Sep; 114():105104. PubMed ID: 34186466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Potent Phosphodiesterase-9 Inhibitors for the Treatment of Hepatic Fibrosis.
    Wu Y; Wang Q; Jiang MY; Huang YY; Zhu Z; Han C; Tian YJ; Zhang B; Luo HB
    J Med Chem; 2021 Jul; 64(13):9537-9549. PubMed ID: 34142552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiestrase-1 and 4 inhibitors ameliorate liver fibrosis in rats: Modulation of cAMP/CREB/TLR4 inflammatory and fibrogenic pathways.
    Essam RM; Ahmed LA; Abdelsalam RM; El-Khatib AS
    Life Sci; 2019 Apr; 222():245-254. PubMed ID: 30858122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Potent and Selective Periphery-Restricted Quinazoline Inhibitors of the Cyclic Nucleotide Phosphodiesterase PDE1.
    Humphrey JM; Movsesian M; Am Ende CW; Becker SL; Chappie TA; Jenkinson S; Liras JL; Liras S; Orozco C; Pandit J; Vajdos FF; Vandeput F; Yang E; Menniti FS
    J Med Chem; 2018 May; 61(10):4635-4640. PubMed ID: 29718668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases.
    Li P; Zheng H; Zhao J; Zhang L; Yao W; Zhu H; Beard JD; Ida K; Lane W; Snell G; Sogabe S; Heyser CJ; Snyder GL; Hendrick JP; Vanover KE; Davis RE; Wennogle LP
    J Med Chem; 2016 Feb; 59(3):1149-64. PubMed ID: 26789933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 2,4-dihydroxyacetophenone derivatives as potent PDE-1 and -3 inhibitors:
    Alam A; Gul S; Zainab ; Khan M; Elhenawy AA; Islam MS; Ali M; Ali Shah SA; Latif A; Ahmad M
    Future Med Chem; 2024; 16(12):1185-1203. PubMed ID: 38989989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent tetracyclic guanine inhibitors of PDE1 and PDE5 cyclic guanosine monophosphate phosphodiesterases with oral antihypertensive activity.
    Ahn HS; Bercovici A; Boykow G; Bronnenkant A; Chackalamannil S; Chow J; Cleven R; Cook J; Czarniecki M; Domalski C; Fawzi A; Green M; Gündes A; Ho G; Laudicina M; Lindo N; Ma K; Manna M; McKittrick B; Mirzai B; Nechuta T; Neustadt B; Puchalski C; Pula K; Zhang H
    J Med Chem; 1997 Jul; 40(14):2196-210. PubMed ID: 9216839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1.
    Abusnina A; Keravis T; Yougbaré I; Bronner C; Lugnier C
    Mol Nutr Food Res; 2011 Nov; 55(11):1677-89. PubMed ID: 22045655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new therapeutic approach in Parkinson's disease: some novel quinazoline derivatives as dual selective phosphodiesterase 1 inhibitors and anti-inflammatory agents.
    Laddha SS; Bhatnagar SP
    Bioorg Med Chem; 2009 Oct; 17(19):6796-802. PubMed ID: 19744861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic nucleotide phosphodiesterase 1A: a key regulator of cardiac fibroblast activation and extracellular matrix remodeling in the heart.
    Miller CL; Cai Y; Oikawa M; Thomas T; Dostmann WR; Zaccolo M; Fujiwara K; Yan C
    Basic Res Cardiol; 2011 Nov; 106(6):1023-39. PubMed ID: 22012077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel selective PDE type 1 inhibitors cause vasodilatation and lower blood pressure in rats.
    Laursen M; Beck L; Kehler J; Christoffersen CT; Bundgaard C; Mogensen S; Mow TJ; Pinilla E; Knudsen JS; Hedegaard ER; Grunnet M; Simonsen U
    Br J Pharmacol; 2017 Aug; 174(15):2563-2575. PubMed ID: 28548283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Novel Quinolin-2(1
    Zhang B; Yang YY; Zhao ZJ; Liu RD; Feng LL; Jiang MY; Yuan Y; Huang S; Li Z; Wang Q; Luo HB; Wu Y
    J Med Chem; 2023 Sep; 66(17):12468-12478. PubMed ID: 37584424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological activities of new thieno[3,2-d] pyrimidines as selective type 4 phosphodiesterase inhibitors.
    Crespo MI; Pagès L; Vega A; Segarra V; López M; Doménech T; Miralpeix M; Beleta J; Ryder H; Palacios JM
    J Med Chem; 1998 Oct; 41(21):4021-35. PubMed ID: 9767640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase 1: A Unique Drug Target for Degenerative Diseases and Cognitive Dysfunction.
    Wennogle LP; Hoxie H; Peng Y; Hendrick JP
    Adv Neurobiol; 2017; 17():349-384. PubMed ID: 28956339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microwave-assisted synthesis of potent PDE7 inhibitors containing a thienopyrimidin-4-amine scaffold.
    Sánchez AI; Meneses R; Mínguez JM; Núñez A; Castillo RR; Filace F; Burgos C; Vaquero JJ; Álvarez-Builla J; Cortés-Cabrera A; Gago F; Terricabras E; Segarra V
    Org Biomol Chem; 2014 Jun; 12(24):4233-42. PubMed ID: 24838636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based discovery of highly selective phosphodiesterase-9A inhibitors and implications for inhibitor design.
    Meng F; Hou J; Shao YX; Wu PY; Huang M; Zhu X; Cai Y; Li Z; Xu J; Liu P; Luo HB; Wan Y; Ke H
    J Med Chem; 2012 Oct; 55(19):8549-58. PubMed ID: 22985069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.